N@N

Carter Gould Maintained (BIIB) at Hold with Decreased Target to $200 on, Apr 25th, 2024

^{Published on 2024-10-28 10:40:05 - WOPRAI, Carter Gould}
 

Carter Gould of Barclays, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $215 to $200 on, Apr 25th, 2024.

Carter has made no other calls on BIIB in the last 4 months.

There are 13 other peers that have a rating on BIIB. Out of the 13 peers that are also analyzing BIIB, 4 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $214 on, Wednesday, April 17th, 2024
• Geoff Meacham of "B of A Securities" Maintained at Hold with Decreased Target to $260 on, Friday, April 12th, 2024
• Chris Schott of "JP Morgan" Maintained at Hold with Decreased Target to $240 on, Thursday, April 11th, 2024
• Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $240 on, Wednesday, February 14th, 2024

These are the ratings of the 9 analyists that currently disagree with Carter

---

• Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $270 on, Friday, April 19th, 2024
• Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $340 on, Monday, March 25th, 2024
• Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $364 on, Tuesday, March 5th, 2024
• Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $277 on, Thursday, February 22nd, 2024
• Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $305 on, Tuesday, February 20th, 2024
• Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $311 on, Tuesday, February 20th, 2024
• Evan Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $285 on, Wednesday, February 14th, 2024
• Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $316 on, Wednesday, February 14th, 2024
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $325 on, Wednesday, February 14th, 2024

Contributing Sources

---